Analysis of the Genomics of Drug Sensitivity in Cancer (GDSC) dataset identified Navitoclax, Methotrexate, and YM201636 as the top compounds showing a positive correlation with PLEK2 expression (Fig. 6c) [30]. The gene discussed is PLEK2; the disease is cancer.